COVID-19-associated cytokine storm syndrome and diagnostic principles: an old and new Issue

References

• WHO Coronavirus Disease. (COVID-19) situation report–Weekly operational update on COVID-19 - 1 February 2021. Geneva: World Health Organization; 2019; https://www.who.int/publications/m/item/weekly-operational-update-on-covid-19---1-february-2021.
   Google Scholar
• Xi YZ, Wang FS. COVID-19-associated cytokine storm syndrome and Its genetic susceptibility: how common or how rare? National Sci Rev. 2021. under review.
   Google Scholar
• Xi YZ. Convalescent plasma therapy for COVID-19: a Tried-and-true old strategy? Signal Trans Targ Ther. 2020;5(1):203.
   Web of Science ®Google Scholar
• Mehta P, McAuley DF, Brown M, et al. HLH across speciality collaboration. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020;395(10299):1033–1034.
   Google Scholar
• Ruscitti P, Berardicurti O, Iagnocco A, et al. Cytokine storm syndrome in severe COVID-19. Autoimmun Rev 2020;19(7):102562.
   PubMed Web of Science ®Google Scholar
• Xu X, Han M, Li T, et al. Effective treatment of severe COVID-19 patients with tocilizumab. Proc Natl Acad Sci USA. 2020;117(20):10970–10975.
   PubMed Web of Science ®Google Scholar
• Moore JB, June CH. Cytokine release syndrome in severe COVID-19. Science. 2020;368(6490):473–474.
   PubMed Web of Science ®Google Scholar
• Schett G, Sticherling M, Neurath MF. COVID-19: risk for cytokine targeting in chronic inflammatory diseases? Nat Rev Immunol. 2020;20(5):271–272.
   PubMed Web of Science ®Google Scholar
• Poston JT, Patel BK, Davis AM. Management of critically ill adults with COVID-19. JAMA. 2020. doi:https://doi.org/10.1001/jama.2020.4914. Epub.
   PubMed Web of Science ®Google Scholar
• Berlin DA, Gulick RM, Martinez FJ. Severe covid-19. N Engl J Med. 2020;383(25):2451–2460.
   PubMed Web of Science ®Google Scholar
• Blanco-Melo D, Nilsson-Payant BE, Liu WC, et al. Imbalanced host response to SARS-CoV-2 drives development of COVID-19. Cell. 2020;181(5):1036–1045.e9.
   PubMed Web of Science ®Google Scholar
• Zhang XN, Tan Y, Ling Y, et al. Viral and host factors related to the clinical outcome of COVID-19. Nature. 2020;583(7816):437–440.
   PubMed Web of Science ®Google Scholar
• La Rosee P, Horne A, Hines M, et al. Recommendations for the management of hemophagocytic lymphohistiocytosis in adults. Blood. 2019;133(23):2465–2477.
   PubMed Web of Science ®Google Scholar
• Cron RQ, Behrens EM, editors. Cytokine storm syndrome 2019. Cham: Springer Nature Switzerland AG. 2019.
   Google Scholar
• Esteban YM, de Jong JLO, Tesher MS. An overview of hemophagocytic lymphohistiocytosis. Pediatric Ann. 2017;46(8):e309–e313.
   PubMed Web of Science ®Google Scholar
• Behrens EM, Koretzky GA. Review: cytokine storm syndrome: looking toward the precision medicine era. Arthrit Rheumat. 2017;69(6):1135–1143.
   PubMed Web of Science ®Google Scholar
• Tisoncik JR, Korth MJ, Simmons CP, et al. Into the eye of the cytokine storm. Microbiol Mol Biol Rev. 2012;76(1):16–32.
   PubMed Web of Science ®Google Scholar
• Brisse E, Matthys P, Wouters CH. Understanding the spectrum of haemophagocytic lymphohistiocytosis: update on diagnostic challenges and therapeutic options. Brit J Haemat. 2016;174(2):175–187.
   PubMed Web of Science ®Google Scholar
• Colafrancesco S, Alessandri C, Conti F, et al. COVID-19 gone bad: a new character in the spectrum of the hyperferritinemic syndrome? Autoimmun. Rev. 2020;19(7):102573.
   PubMed Web of Science ®Google Scholar
• Pivonello R, Auriemma RS, Pivonello C, et al. Sex disparities in COVID-19 severity and outcome: are men weaker or women stronger? Neuroendocrinology. 2020 Nov 26. doi:https://doi.org/10.1159/000513346. Online ahead of print.
   Google Scholar
• Yang X Y, Xu J, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020;8(5):475–481.
   Web of Science ®Google Scholar
• Xu J, Yang X, Yang L, et al. Clinical course and predictors of 60-day mortality in 239 critically ill patients with COVID-19: a multicenter retrospective study from Wuhan, China. Crit Care. 2020;24(1):394.
   PubMed Web of Science ®Google Scholar
• Vepa A, Bae JP, Ahmed F, et al. COVID-19 and ethnicity: a novel pathophysiological role for inflammation. Diabetes Metab Syndr. 2020;14(5):1043–1051.
   PubMed Web of Science ®Google Scholar
• Violetis OA, Chasouraki1 AM, Giannou1 AM, Baraboutis IG. COVID-19 Infection and haematological involvement: a review of epidemiology, pathophysiology and prognosis of full blood count findings. SN Comprehensive Clinical Medicine. 2020 Jun29:1–5. doi:https://doi.org/10.1007//s42399-020-00380-3. Online ahead of print.
   Google Scholar
• Silva AC, Lobo JMS. Cytokines and growth factors. Adv Biochem Eng Biotechnol. 2020;171(1):87–113.
   Google Scholar
• Stone WL, LeavittL, Varacallo M. Physiology, growth factor. In: Statpearls [Internet]. Treasure Island (FL): StatPearls Publishing 2020. pp. 1–5.
   Google Scholar
• Bhusal RP, Foster SR, Stone MJ. Structural basis of chemokine and receptor interactions: KEY regulators of leukocyte recruitment in inflammatory responses. Protein Sci 2020;29(2):420–432.
   Web of Science ®Google Scholar
• Gustavsson M, Gustavsson M. New insights into the structure and function of chemokine receptor: chemokine complexes from an experimental perspective. J Leukoc Biol. 2020;107(6):1115–1122.
   Web of Science ®Google Scholar
• Steeland S, Libert C, Vandenbroucke RE. A new venue of TNF targeting. Int J Mol Sci. 2018;19(5):1442.
   Web of Science ®Google Scholar
• Jamilloux Y, Henry T, Belot A, et al. Should we stimulate or suppress immune responses in COVID-19? Cytokine and anti-cytokine interventions. Autoimmun Rev. 2020;19(7):102567.
   PubMed Web of Science ®Google Scholar
• McGonagle D, Sharif K, O'Regan A, et al. The role of cytokines including interleukin-6 in COVID-19 induced Pneumonia and macrophage activation syndrome-like disease. Autoimmun Rev. 2020;19(6):102537.
   PubMed Web of Science ®Google Scholar
• Coperchini F, Chiovato L, Croce L, et al. The cytokine storm in COVID-19: an overview of the involvement of the chemokine/chemokine-receptor system. Cytokine Growth Factor Rev. 2020;53(1):25–32.
   Google Scholar
• Wong CK, Lam CW, Wu AK, et al. Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome. Clin Exp Immunol. 2004;136(1):95–103.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Li J, Zhan Y, et al. Analysis of serum cytokines in patients with severe acute respiratory syndrome. Infect Immun. 2004;72(8):4410–4415.
   PubMed Web of Science ®Google Scholar
• Zhou J, Chu H, Li C, et al. Active replication of middle east respiratory syndrome coronavirus and aberrant induction of inflammatory cytokines and chemokines in human macrophages: implications for pathogenesis. J Infect Dis. 2014;209(9):1331–1342.
   PubMed Web of Science ®Google Scholar
• Lau SKP, Lau CCY, Chan KH, et al. Delayed induction of proinflammatory cytokines and suppression of innate antiviral response by the novel Middle East respiratory syndrome coronavirus: implications for pathogenesis and treatment. J Gen Virol. 2013;93(Pt12):2679–2690.
   Google Scholar
• Channappanavar R, Perlman S. Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology. Semin Immunopathol. 2017;39(5):529–539.
   PubMed Web of Science ®Google Scholar
• Aziz M, Fatima R, Assaly R. Elevated interleukin-6 and severe COVID-19: a meta-analysis. J Med Virol. 2020;92(11):2283–2285.
   PubMed Web of Science ®Google Scholar
• Henter JI, Horne A, Aricó M, et al. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2007;48(2):124–131.
   PubMed Web of Science ®Google Scholar
• Filipovich AH. Hemophagocytic lymphohistiocytosis (HLH) and related disorders. Hematol Am Soc Hematol Educ Program. 2009;12(1):127–131.
   Google Scholar
• Schweizer M, Goede JS, Briner V. Patients with an extraordinarily elevated serum ferritin: think of haemophagocytic lymphohistiocytosis. Swiss Med Wkly. 2015;145:w14152.
   Web of Science ®Google Scholar
• Zhang Q, Li L, Zhu L, et al. Adult onset haemophagocytic lymphohistiocytosis prognosis is affected by underlying disease: analysis of a single-institution series of 174 patients. Swiss Med Wkly. 2018;148:w14641.
   Web of Science ®Google Scholar
• Caricchio R, Gallucci M, Dass C, et al. Preliminary predictive criteria for COVID-19 cytokine storm. Ann Rheum Dis. 2021;80(1):88–95.
   PubMed Web of Science ®Google Scholar
• Che WX. Hemophagocytic cell and hemophagocytic syndrome. J Clin Hematol. 2018;31(5):867–869.
   Google Scholar
• Signoff JK, Fitzgerald JC, Teachey DT, et al. Hypofibrinogenemia Is associated With poor Outcome and secondary hemophagocytic lymphohistiocytosis/macrophage activation syndrome in pediatric severe sepsis*. Pediatr Crit Care Med. 2018;19(5):397–405.
   Web of Science ®Google Scholar
• Jordan MB, Allen CE, Weitzman S, et al. How I treat hemophagocytic lymphohistiocytosis. Blood. 2011;118(15):4041–4052.
   PubMed Web of Science ®Google Scholar
• Machaczka M, Klimkowska M. Bone marrow assessment in the diagnosis of acquired hemophagocytic lymphohistiocytosis in adults. Am J Clin Pathol. 2015;143(2):308–309.
   Web of Science ®Google Scholar
• Verma T, Aggarwal S. Childhood tuberculosis presenting with haemophagocytic syndrome. Indian J Hematol Blood Transfus. 2012;28(3):178–180.
   Web of Science ®Google Scholar
• Ho C, Yao X, Tian L, et al. Marrow Assessment for hemophagocytic lymphohistiocytosis Demonstrates poor Correlation With disease Probability. Am J Clin Pathol. 2014;141(1):62-71.
   Web of Science ®Google Scholar
• Ramos-Casals M, Brito-Zerón P, López-Guillermo A, et al. Adult haemophagocytic syndrome. Lancet. 2014;383(9927):1503–1516.
   PubMed Web of Science ®Google Scholar